Register Login PRODUCTS Anaesthesia & Respiratory Baby Casting Continence Care Diagnostic Ear Irrigation Equipment General Consumables Gloves Hand & Body Hygiene Infection Prevention & Control Intravenous Infusion & Administration Medical & Surgical Instruments Medical Lighting Needles & Syringes Nutritional Support Oral Care Patient Monitoring Pharmaceuticals Rehabilitation & Mobility Skin Care Sports & Recovery Sterilisation Sutures & Skin Closures Urology Vaccines Wound Care News & Updates Brands About Us Contact Us Register Login Menu PRODUCTS Anaesthesia & Respiratory Baby Casting Continence Care Diagnostic Ear Irrigation Equipment General Consumables Gloves Hand & Body Hygiene Infection Prevention & Control Intravenous Infusion & Administration Medical & Surgical Instruments Medical Lighting Needles & Syringes Nutritional Support Oral Care Patient Monitoring Pharmaceuticals Rehabilitation & Mobility Skin Care Sports & Recovery Sterilisation Sutures & Skin Closures Urology Vaccines Wound Care News & Updates Brands Nursing Supplies Student Supplies About Us Contact Us Please enter your email address to subscribe to our newsletters.
Patients received either pemetrexed for injection 500 mg/m2 intravenously and cisplatin 75 mg/m2 intravenously on Day 1 of each 21-day cycle (n=839) or gemcitabine 1250 mg/m2 intravenously on Days 1 and 8 and cisplatin 75 mg/m2 intravenously on Day 1 of each 21-day cycle (n=830)
ALA also demonstrated improvement with cognitive function in senescence-accelerated mice and in chemically-induced, aging-accelerated mice
Ann Microbiol 66(2):569576
Abstract Background: Parkinsons disease psychosis (PDP) is a common and distressing complication of Parkinsons disease (PD), characterized by hallucinations and delusions
With a lower cadmium/zinc quotient, cells are more protected, while an increased quotient reduces this protection due to the decreased availability of zinc sites for cadmium interaction
